http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2070010-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f03cffdee00cc69a7eb39695f836ffc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbfd3d3ff74634313d400e8c4a4ef496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d4ed12582875755eae1054c3b9701c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_944ea1dab3876adecb8b351d7b02eecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b8c7d4e36859560d06b2a9cd374ed15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e2987c1bd7783f7a37f57625c5946f9
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 1993-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae10d8f43cc70f45d73d000b23675e66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bc90ff2f33976aae0763a6edd10b617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c51f5906241e0052b7d2561db241bcd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88988537bc98f950bb184e9bb6b3e689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_affa2bfad825c2430349d95db23bf5e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d1ace1d37f43781345a4ba68161d2db
publicationDate 1996-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2070010-C1
titleOfInvention Agent for antioxidant protection of eye media and tissues
abstract FIELD: medicine, ophthalmology. SUBSTANCE: agent is biosoluble polymer with hydrophilic plasticizing addition and has emoxipin and pyridoxine hydrochloride at corresponding quantitative ratio of components. Agent shows local prolonged action and presents noninvasive agent for treatment of progressive and complicated myopia, open-angle glaucoma, diabetic retinopathy, intraocular hemorrhage of different etiology. EFFECT: enhanced effectiveness of treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009501712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101233110-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8044210-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2815541-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007017713-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0234201-A3
priorityDate 1993-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450463518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454671007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID128852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497675

Total number of triples: 41.